Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet.
Armstrong AJ, Antonarakis ES, Taplin ME, Kelly WK, Beltran H, Fizazi K, Dahut WL, Shore N, Slovin S, George D, Carducci MA, Corn P, Danila D, Dreicer R, Heath E, Rathkopf D, Liu G, Nanus D, Stein M, Smith MR, Sternberg C, Wilding G, Nelson PS, Halabi S, Kantoff P, Clarke NW, Evans CP, Heidenreich A, Mottet N, Gleave M, Morris MJ, Scher HI. Armstrong AJ, et al. Among authors: evans cp. Ann Oncol. 2018 Jan 1;29(1):23-25. doi: 10.1093/annonc/mdx648. Ann Oncol. 2018. PMID: 29088323 Free PMC article. No abstract available.
What's hot in the prostate?
Gleave M, Evans C. Gleave M, et al. Prostate Cancer Prostatic Dis. 2002;5(3):168-71. doi: 10.1038/sj.pcan.4500618. Prostate Cancer Prostatic Dis. 2002. PMID: 12496976 No abstract available.
What's hot in the prostate?
Gleave M, Evans CP. Gleave M, et al. Among authors: evans cp. Prostate Cancer Prostatic Dis. 2003;6(3):200-3. doi: 10.1038/sj.pcan.4500678. Prostate Cancer Prostatic Dis. 2003. PMID: 12970721 No abstract available.
What's hot in the prostate?
Gleave M, Evans CP. Gleave M, et al. Among authors: evans cp. Prostate Cancer Prostatic Dis. 2003;6(4):268-71. doi: 10.1038/sj.pcan.4500699. Prostate Cancer Prostatic Dis. 2003. PMID: 14663465 No abstract available.
What's hot in the prostate?
Gleave M, Evans CP. Gleave M, et al. Among authors: evans cp. Prostate Cancer Prostatic Dis. 2004;7(4):273-6. doi: 10.1038/sj.pcan.4500773. Prostate Cancer Prostatic Dis. 2004. PMID: 15592439 No abstract available.
Traditional approaches to androgen deprivation therapy.
Moul JW, Evans CP, Gomella LG, Roach M 3rd, Dreicer R. Moul JW, et al. Among authors: evans cp. Urology. 2011 Nov;78(5 Suppl):S485-93. doi: 10.1016/j.urology.2011.05.051. Urology. 2011. PMID: 22054920
Enzalutamide in metastatic prostate cancer before chemotherapy.
Beer TM, Armstrong AJ, Rathkopf DE, Loriot Y, Sternberg CN, Higano CS, Iversen P, Bhattacharya S, Carles J, Chowdhury S, Davis ID, de Bono JS, Evans CP, Fizazi K, Joshua AM, Kim CS, Kimura G, Mainwaring P, Mansbach H, Miller K, Noonberg SB, Perabo F, Phung D, Saad F, Scher HI, Taplin ME, Venner PM, Tombal B; PREVAIL Investigators. Beer TM, et al. Among authors: evans cp. N Engl J Med. 2014 Jul 31;371(5):424-33. doi: 10.1056/NEJMoa1405095. Epub 2014 Jun 1. N Engl J Med. 2014. PMID: 24881730 Free PMC article. Clinical Trial.
The role of microRNA in castration-resistant prostate cancer.
Thieu W, Tilki D, de Vere White R, Evans CP. Thieu W, et al. Among authors: evans cp. Urol Oncol. 2014 Jul;32(5):517-523. doi: 10.1016/j.urolonc.2013.11.004. Urol Oncol. 2014. PMID: 24935732 Free PMC article. Review.
The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer.
Evans CP, Higano CS, Keane T, Andriole G, Saad F, Iversen P, Miller K, Kim CS, Kimura G, Armstrong AJ, Sternberg CN, Loriot Y, de Bono J, Noonberg SB, Mansbach H, Bhattacharya S, Perabo F, Beer TM, Tombal B. Evans CP, et al. Eur Urol. 2016 Oct;70(4):675-683. doi: 10.1016/j.eururo.2016.03.017. Epub 2016 Mar 19. Eur Urol. 2016. PMID: 27006332 Clinical Trial.
240 results